Literature DB >> 23723023

Pathological consequences of intermittent hypoxia in the central nervous system.

Shelley X L Zhang1, Yang Wang, David Gozal.   

Abstract

Intermittent hypoxia (IH) is a frequent occurrence in clinical settings. In the last decades, evidence has emerged implicating the gas exchange alterations and sleep disruption associated with those disorders in the high prevalence of cognitive and behavioral deficits afflicting these patients. In an effort to better characterize the role of IH, and to identify potential mechanisms of IH-induced central nervous system (CNS) dysfunction, a large number of rodent models have been recently developed. The cumulative evidence confirms that IH indeed induces a heterotopic pattern of injury in the brain, particularly affecting cortical, subcortical, and hippocampal regions, ultimately leading to neuronal apoptosis and activation of microglia. These IH-induced deleterious processes exhibit substantial variability across the lifespan, are under substantial modulatory influences of diet, physical or intellectual activity, and genetic factors, and preferentially recruit oxidative stress and inflammatory pathways.
© 2012 American Physiological Society. Compr Physiol 2:1745-1766, 2012.

Entities:  

Mesh:

Year:  2012        PMID: 23723023     DOI: 10.1002/cphy.c100060

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  21 in total

Review 1.  Sleep Apnea Research in Animals. Past, Present, and Future.

Authors:  Swati Chopra; Vsevolod Y Polotsky; Jonathan C Jun
Journal:  Am J Respir Cell Mol Biol       Date:  2016-03       Impact factor: 6.914

2.  Interactive effects of maternal cigarette smoke, heat stress, hypoxia, and lipopolysaccharide on neonatal cardiorespiratory and cytokine responses.

Authors:  Fiona B McDonald; Kumaran Chandrasekharan; Richard J A Wilson; Shabih U Hasan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-10-12       Impact factor: 3.619

3.  Impaired Lung Function, Lung Disease, and Risk of Incident Dementia.

Authors:  Pamela L Lutsey; Nemin Chen; Maria C Mirabelli; Kamakshi Lakshminarayan; David S Knopman; Keith A Vossel; Rebecca F Gottesman; Thomas H Mosley; Alvaro Alonso
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

Review 4.  Neural Control of the Upper Airway: Respiratory and State-Dependent Mechanisms.

Authors:  Leszek Kubin
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

Review 5.  Therapeutic acute intermittent hypoxia: A translational roadmap for spinal cord injury and neuromuscular disease.

Authors:  Alicia K Vose; Joseph F Welch; Jayakrishnan Nair; Erica A Dale; Emily J Fox; Gillian D Muir; Randy D Trumbower; Gordon S Mitchell
Journal:  Exp Neurol       Date:  2021-10-09       Impact factor: 5.330

Review 6.  Hypoxia-inducible factors and obstructive sleep apnea.

Authors:  Nanduri R Prabhakar; Ying-Jie Peng; Jayasri Nanduri
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

7.  Cerebral and Muscle Oxygenation During Intermittent Hypoxia Exposure in Healthy Humans.

Authors:  Thomas Rupp; Arthur Peyrard; Renaud Tamisier; Jean-Louis Pepin; Samuel Verges
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

8.  Repetitive acute intermittent hypoxia does not promote generalized inflammatory gene expression in the rat CNS.

Authors:  Megan E Peters; Rebecca S Kimyon; Gordon S Mitchell; Jyoti J Watters
Journal:  Respir Physiol Neurobiol       Date:  2015-07-26       Impact factor: 1.931

Review 9.  Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity.

Authors:  Abdelnaby Khalyfa; Leila Kheirandish-Gozal; David Gozal
Journal:  Respir Physiol Neurobiol       Date:  2017-07-01       Impact factor: 1.931

10.  Chronic intermittent hypoxia exerts CNS region-specific effects on rat microglial inflammatory and TLR4 gene expression.

Authors:  Stephanie M C Smith; Scott A Friedle; Jyoti J Watters
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.